Public Meeting Notice

Public Meeting Notice Board of Registration in Pharmacy meeting — June 2, 2022

Thursday, June 2, 2022 at 8 a.m.
  • Posted: May 5, 2022 7:46 a.m.
  • Last Updated: June 29, 2022 10:02 p.m.

Overview of Board of Registration in Pharmacy meeting — June 2, 2022

This meeting will be by Webex conference call.

Webex access

Phone access

  • Call-in number: 1-650-479-3208
  • Access code: 2535 798 9170
  • Attendee: #

If you need reasonable accommodations in order to participate in the meeting, contact the DPH ADA Coordinator Sofie Daley, in advance of the meeting. While the Board will do its best to accommodate you, certain accommodations may require distinctive requests or the hiring of outside contractors and may not be available if requested immediately before the meeting.


Item # Item
I Call to order
II Approval of agenda
III Approval of Board Minutes
  • Draft of May 5, 2022 regular session minutes
IV Reports
  • Applications approved pursuant to Licensure Policy 13-01
  • Monthly report from Probation
  • Board Delegated Review pursuant to Licensure Policy 14-02
  • PSUD Report-Policy 17-03
V Flex
  • Pharmacy issues related to COVID-19
  • PSUD Rehabilitation Evaluation Committee- MD appointment, Jasra Ali Bhat, MD
  • NABP Annual Meeting Summary
VI Applications
  • Walgreens — Central Fill Request
VII Policy
  • Policy 2022-03: Unfilled Prescriptions
VIII File Review
1 CAS-2022-0105 SA-INV-19318 MyLyfe Specialty Pharmacy, DS90324
2 CAS-2021-0827 SA-INV-18403 Long Term Pharmacy Solutions, DS90330
3 CAS-2021-1140 SA-INV-19031 Edge Pharma, NO00015
4 CAS-2022-0982 PHA-2021-0094 Walgreens #2977, DS2250
5 CAS-2021-0976 SA-INV-18622 Stuart Tolman, PH238753
6 CAS-2022-1099 PHA-2021-0106 Big Y #22, DS89811
7 CAS-2021-0862 PHA-2022-0012 Amy Joseph, PH24935
8 CAS-2021-1200 PHA-2021-0115 CVS #224, DS20589
9 CAS-2021-1100 PHA-2021-0107 CVS #16613, DS90022
10 CAS-2022-0187 PHA-2022-0027 CVS #1844, DS89666
11 CAS-2022-0186 PHA-2022-0026 CVS #1006, DS2715
12 CAS-2022-0166 PHA-2022-0053 CVS #23, DS90049
13 CAS-2022-0179 PHA-2022-0022 CVS #23, DS90049
14 CAS-2022-0181 PHA-2022-0023 CVS #127, DS3420
15 CAS-2022-0184 PHA-2022-0025 CVS #291, DS3271
16 CAS-2021-1281 PHA-2021-0120 CVS #1248, DS2875
17 CAS-2022-0051 PHA-2022-0008 CVS #444, DS2704
18 CAS-2022-0389 PHA-2022-0080 CVS #1252, DS3612
IX Executive Session
The Board will meet in Executive Session as authorized pursuant to M.G.L. c. 30A, § 21(a)(1) for the purpose of discussing the reputation, character, physical condition, or mental health, rather than professional competence, of an individual, or to discuss the discipline or dismissal of, or complaints or charges brought against, a public officer, employee, staff member or individual. Specifically, to evaluate the Good Moral Character as required for registration for a pending applicant.
X M.G.L. c. 112, § 65C Session
XI Adjournment